Clinical Trial Update: Renal Denervation by Iberis MultiElectrode Renal Denervation System in Patients With Primary Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the Iberis MultiElectrode Renal Denervation System for primary hypertension; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Iberis MultiElectrode Renal Denervation System

Snippet

Sponsor: Shanghai AngioCare Medical | Conditions: Primary Hypertension | Phase 3 | Status: UNKNOWN